To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us." -Dr. John Farley

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.

The findings, published in the Feb. 14 edition of The Lancet Oncology, show that selumetinib targets a mutation in the MAPK pathway for patients with low-grade serous carcinoma, allowing for treatment on previously chemoresistant tumors.

"This is a potentially important breakthrough for the Gynecologic Oncology Group," said John Farley, MD, a gynecologic oncologist in the Division of Gynecologic Oncology and the Department of Obstetrics and Gynecology at the Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, a Dignity Health Member.

This study was initially developed in 2007, with 52 patients enrolled for the Phase II clinical trial between December 2007 and November 2009. Patients were given 50 milligrams of selumetinib orally twice daily. Of those participants, eight had a measurable decrease in tumor size, seven had partial responses and 34 patients saw their tumors stabilize. The findings suggest that inhibitors of the MAPK pathway warrant further investigation in patients with low-grade ovarian cancer.

"There just aren't very good treatments for low-grade ovarian cancer, so this discovery opens up a lot of new exciting possibilities for us," Dr. Farley said. He added that Phase III of this trial is scheduled to begin in the next few weeks, with that trial to be the "definitive test" before the treatment becomes available to the general population.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Ahead of the 250th Anniversary of America, the BIBLE Will Be Read Cover-to-Cover in DC

'We Saw Over 500 Make Decisions for Christ': Revival Hits Texas Universities

Shameful: Arkansas Gov Huckabee Asked to Leave Restaurant by Triggered Staff

Why Did the Biden Administration Cover Up Chinese Interference in Our Elections?

Fulton County Numbers Don't Match after FBI Seizure

Supreme Court Gears Up to Decide If Elections End on Election Day

Women's Soccer Team Disappears into Iran as the Threat of Executions Loom

Chuck Norris Passes Away after Sudden Hospitalization from Medical Emergency

'We Sensed the Hand of God': Group of Christians Experience Divine Protection from Iran's Missiles

Group That Sets Agenda for 130K School Counselors Pushes Woke Program

Over a Dozen Christian leaders urge Trump to Protect Afghan Christians from Deportation

House Narrowly Passes Legislation to Deport Illegal Immigrants Participating in Welfare Fraud

Report: FBI Has Been Investigating Joe Kent for Months over Classified Leak Allegations

Iran's Islamic Regime Executes Iranian Champion Wrestler in 'Barbaric' Public Hanging amid War

Saudis Unite Arab World against Iran's Regime: Trust 'Has Completely Been Shattered'

Europe Finally Steps Up, Backs US in the Strait of Hormuz

Joe Rogan: 'I'm Fascinated by the Story of Jesus Christ' [Video]

Politicians Called It a 'Chemtrail Conspiracy.' The CIA's Own Files Just Proved Them Wrong

Scotland's Parliament Votes against Assisted Suicide in Pro-Life Victory

Weird: Iraq-Born Man Released from Jail after Bringing Gun, Wearing Tactical Gear, to Texas Elementary School

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor